HDFC Life Insurance reported APE of Rs 32.3 billion (in-line) in Q1 FY26, up 13% YoY, driven by 13%/12% YoY growth in individual/group APE. For Q1 FY26, HDFC Life reported a 14% YoY growth in shareholders’ PAT to Rs 5.5 billion, (11% beat), supported by a 15% increase in back-book profits.
NDTV Profit’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer NDTV Profit’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
Motilal Oswal Report
HDFC Life Insurance Company Ltd. continues to focus on enhancing channel economics through a multipronged strategy—diversifying the product mix, driving cross-sell and upsell, leveraging the bank’s digital assets, and improving customer experience.
We have trimmed our value of new business margin assumptions by 50bp each for FY26/27 to reflect the Q1 FY26 performance and management’s guidance of flattish margins.
We reiterate Buy with a target price of Rs 910 (based on 2.6x FY27E embedded value).
Click on the attachment to read the full report:
DISCLAIMER
This report is authored by an external party. NDTV Profit does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of NDTV Profit.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.
RECOMMENDED FOR YOU

Stock Picks Today: What Brokerages Are Saying About HDFC Life, ICICI Lombard, ICICI Prudential, And More


HDFC Life Insurance Q1 Results: Profit Up 14%, Net Premium Income Rises 15%


Angel One, HDFC Life, Nuvama Among Motilal Oswal's Top Stock Bets In Non-Lending Financials; Q1 Result Preview


Motilal Oswal Stays 'Neutral' On Axis Max Life, Revises Target Price — Here's Why
